Unaltered monocyte function in patients with major depression before and after three months of antidepressive therapy

Biological Psychiatry

Volumn 41, Issue 6, 1997, Pages 675-681

  Landmann, Regine ^a   Schaub, Brigitte ^a   Link, Susanne ^a   Wacker, Hans Rudolf ^a  

^a UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

depression; dexamethasone; human leukocyte antigen CD14; human leukocyte antigen class II; monocyte function; tumor necrosis factor

Indexed keywords

AMITRIPTYLINE; CLOMIPRAMINE; CORTICOSTEROID; FLUVOXAMINE; INTERFERON; LEUKOCYTE ANTIGEN; MAPROTILINE; MOCLOBEMIDE; NEOPTERIN; TRICYCLIC ANTIDEPRESSANT AGENT; TRIMIPRAMINE; TUMOR NECROSIS FACTOR;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DEPRESSION; DEXAMETHASONE SUPPRESSION TEST; FEMALE; HUMAN; MALE; MONOCYTE; PRIORITY JOURNAL;

ADOLESCENT; ADULT; AGED; ANTIDEPRESSIVE AGENTS; ANTIGENS, CD14; BENZAMIDES; CENTRAL NERVOUS SYSTEM AGENTS; CYTOKINES; DEPRESSIVE DISORDER; DEXAMETHASONE; FEMALE; FLOW CYTOMETRY; HISTOCOMPATIBILITY ANTIGENS CLASS II; HUMANS; INTERFERON TYPE II; MALE; MIDDLE AGED; MOCLOBEMIDE; MONOCYTES; PSYCHIATRIC STATUS RATING SCALES;

EID: 0030955430     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(96)00176-X     Document Type: Article

References (31)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington DC: American Psychiatric Press.
2. Angst J, Stahl M (1992): Efficacy of moclobemide in different patient groups. A meta-analysis of studies. Psychopharmacology 106:S109-S113.
3. APA Task Force on Laboratory Tests in Psychiatry (1987): The dexamethasone suppression test: An overview of its current status in psychiatry. Am J Psychiatry 144:1253-1262.
4. Arana W, Baldessarini RJ, Ornsteen M (1985): The dexamethasone suppression test for diagnosis and prognosis in psychiatry. Arch Gen Psychiatry 42:1193-1204.
5. Benfield TL, Schattenkerk JKME, Hofmann B, Jensen BN, Nielsen TL, Lundgren JD (1994): Differential effect on serum neopterin and serum beta-2-microglobulin is induced by treatment in pneumocystis carinii pneumonia. J Infect Dis 169:1170-1173.
6. Da Prada M, Zürcher G (1976): Simultaneous radioenzymatic determination of plasma and tissue adrenaline, noradrenaline and dopamine within the femtomole range. Life Sci 19:1161-1167.
7. Felten DL, Cohen N, Ader R, Felten SY, Carlson SL, Roszman TL (1991): Central neural circuits involved in neural-immune interactions. In Ader R, Felten DL, Cohen N (eds), Psychoneuroimmunology, 2nd ed. San Diego, CA: Academic Press, pp 3-25.
8. Fertsch-Ruggio D, Schoenberg DR, Vogel S (1988): Induction of macrophage la antigen expression by rIFNg and downregulation by IFN a/b and dexamethasone are regulated transcriptionally. J Immunol 141:1582-1589.
9. Gallati H, Pracht I, Schmidt J, Häring P, Garotta G (1987): A simple rapid and large capacity ELISA for biologically active native and recombinant human interferon-gamma. J Biol Regul Homeost Agents 1:109-118.
10. Gold PW, Goodwin FK, Chrousos GP (1988a): Clinical and biochemical manifestations of depression, first of two parts. N Engl J Med 319:348-353.
11. Gold PW, Goodwin FK, Chrousos GP (1988b): Clinical and biochemical manifestations of depression, second of two parts. N Engl J Med 319:413-420.
12. Halloran PF (1993): Interferon-gamma, prototype of the proinflammatory cytokines - Importance on activation, suppression and maintenance of the immune response. Transplant Proc 25:10-15.
13. Hamilton M (1967): Development of a rating scale for primary depressive illness. J Soc Clin Psychol 6:278-296.
14. Landmann R, Wesp M, Dukor P (1988): Modulation of interferon-gamma-induced major histocompatibility (MHC) and CD14 antigen changes by lipophilic muramyltripeptide MTP-PE in human monocytes. Cell Immunol 117:45-55.
15. Landmann R, Wesp M, Ludwig C, Obrist R, Knüsli C, Obrecht JP (1990): Recombinant interferon-gamma upregulates in vivo and downregulates in vitro monocyte CD14 antigen expression in cancer patients. Cancer Immunol Immunother 31:292-296.
16. Landmann R, Obrist R, Obecht JP (1991): Effect of cytokines and lipopolysaccharide on monocyte CD14 antigen expression. J Cell Biochem 47:317-329.
17. National Institute of Mental Health (1981): Clinical Global Impressions, Vol 12. Weinheim: Beltz, GmbH.
18. Nelson C, Mazure CM, Jatlow PI (1990): Value of the DST for predicting response of patients with major depression to hospitalization and desipramine. Am J Psychiatry 147:1488-1492.
19. Nemeroff CB, Wilderlöv EB, Bisette G (1984): Elevated concentrations of CSF corticotropin-releasing factor-like immunoreactivity in depressed patients. Science 226:1342-1344.
20. Rush AJ, Weissenburger JE (1994): Melancholic symptom features and DSM-IV. Am J Psychiatry 151:489-498.
21. Schleifer SJ, Keller SE, Bond RN, Cohen J, Stein M (1989): Major depressive disorder and immunity. Arch Gen Psychiatry 46:81-87.
22. Shen L, Guyre PM, Ball M, Fanger MW (1986): Glucocorticoid enhances gamma interferon effects on human monocyte antigen expression and ADCC. Cell Immunol 65:387-395.
23. Stabl M, Bizière K, Schmid-Burgk W, Amrein R (1989): Review of comparative clinical trials: Moclobemide versus tricyclic antidepressants and versus placebo in depressive states. J Neural Transm Suppl 28:77-89.
24. Stein M, Miller AH, Trestman RL (1991): Depression, the immune system, and health and illness. Arch Gen Psychiatry 48:171-177.
25. Syvalahti E, Eskola J, Ruuskanen O, Laine T (1985): Nonsuppression of cortisol and immune function. Prog Neuropsychopharmacol Biol Psychiatry 9:413-422.
26. Tonnesen E, Christensen NJ, Brinklov MM (1987): Natural killer cell activity during cortisol and adrenaline infusion in healthy volunteers. Eur J Clin Invest 17:497-503.
27. Tracey KJ, Cerami A (1994): Tumor necrosis factor: A pleiotropic cytokine and therapeutic target. Annu Rev Med 45:491-503.
28. Waage A, Bakke O (1988): Glucocorticoids suppress the production of TNF by LPS-stimulated human monocytes. Immunology 63:299-302.
29. Wachter H, Fuchs D, Hausen A, Reibenegger G, Werner ER (1989): Neopterin as marker for activation of cellular immunity: Immunologic basis and clinical application. Adv Clin Chem 27:81-141.
30. Wright SD, Ramos RA, Tobias PS, Ulevitch RJ, Mathison JC (1990): CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein. Science 249:1431-1433.
31. Zung WW (1965): A self-rating depression scale. Arch Gen Psychiatry 12:63-70.